Recommendations for using intravenous fibrinolysis in stroke patients;Recommandations pour l'utilisation du traitement thrombolytique intra-veineux dans l'accident ischémique cérébral

Revue Neurologique

Volumn 156, Issue 12, 2000, Pages 1178-1185

  Larrue, V ^a   Amarenco, P ^b   Caussanel, J P ^a   Ducrocq, X ^a   Lucas, C ^a   Mahagne, M H ^a   Rouanet, F ^a   Baron, J C ^a   Baumelou, B ^a   Boulliat, J ^a   Bousser, M G ^b   Bracard, S ^a   Castel, J P ^a   Chopard, J L ^a   Dechy, H ^a   Ellie, E ^a   Giroud, M ^a   Goldstein, P ^a   Hinault, P ^a   Hommel, M ^a   Leys, D ^a   Maiza D ^a   Mas, J L ^a   Masson, C ^a   Moulin, T ^a   Mounier Vehier, F ^a   Rancurel, G ^c   Trouillas, P ^a   Branchereau, A ^a   more..

^a Lariboisière ^*

^b Private Clinic and University Hospital of Lariboisière   (France)

^c Paris la Salpêtrière   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; STREPTOKINASE;

BRAIN HEMORRHAGE; BRAIN SCINTISCANNING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FIBRINOLYSIS; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; META ANALYSIS; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STROKE;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; FRANCE; HUMANS; INFUSIONS, INTRAVENOUS; THROMBOLYTIC THERAPY;

EID: 0034519950     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Prospective, monitored, multicenter post-approval experience with intravenous t-PA for treatment of acute stroke: The standard treatment with activase to reverse stroke (STARS) study
2. Routine use of thrombolysis: Experienced centers report better outcome
3. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: A randomized controlled trial
4. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
5. Trials of streptokinase in severe acute ischaemic stroke
6. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach
7. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS 2)
8. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European cooperative acute stroke study (ECASS)
9. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study
10. Early recanalization in acute ischaemic stroke saves tissue at risk defined by MRI
11. The great Cincinatti T-PA experience after the NINDS trial: Does a longer time to treatment within the current three-hour window reduce efficacy?
12. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European cooperative acute stroke study
13. Improved reliability of NIH stroke scale using video training
14. Thrombolytic therapy with streptokinase in acute ischemic stroke
15. Tissue plasminogen activator for acute ischemic stroke
16. Cerebral hemorrhage after intravenous therapy for ischemic stroke
17. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke
18. Thrombolysis with intravenous rt-PA in a series of 100 cases of acute carotid territory stroke. Determination of etiological, topographic, and radiological outcome factors
19. Effect of training on the recognition of large ischemic lesions on CT scans obtained within 6 hours of onset
20. The extent of ischemic brain oedema and the response to rt-PA in ECASS 2
21. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke